Outcomes of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation

Haematologica. 2018 May;103(5):e211-e214. doi: 10.3324/haematol.2017.184564. Epub 2018 Jan 25.

¹ Department of Hematology, Osaka International Cancer Institute, Tokyo, Japan [email protected].
² Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
³ Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
⁴ Department of Hematology, Kumamoto University Hospital, Okinawa, Japan.
⁵ Department of Hematology, Heart-Life Hospital, Okinawa, Japan.
⁶ Department of Hematology, National Hospital Organization Kagoshima Medical Center, Nagasaki, Japan.
⁷ Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
⁸ Department of Hematology, Sasebo City General Hospital, Nagasaki, Japan.
⁹ Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
¹⁰ Department of Hematology, Respiratory Medicine and Oncology, Saga University School of Medicine, Fukuoka, Japan.
¹¹ Department of Hematology, National Hospital Organization Nagasaki Medical Center, Fukuoka, Japan.
¹² Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
¹³ Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan.
¹⁴ Department of Hematology, Osaka International Cancer Institute, Tokyo, Japan.

No abstract available

Publication types